Schedule 13G ownership disclosure

ASPIRE BIOPHARMA HLDGS INC

Class A Common Stock · CUSIP: 738920107

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Harraden Circle Investments, LLC

    Shares: 150,000 · Class: 0.31%

  • Harraden Circle Investors GP, LP

    Shares: 133,173 · Class: 0.27%

  • Harraden Circle Investors GP, LLC

    Shares: 133,173 · Class: 0.27%

  • Harraden Circle Investors, LP

    Shares: 95,673 · Class: 0.2%

  • Harraden Circle Special Opportunities, LP

    Shares: 37,500 · Class: 0.08%

  • Harraden Circle Strategic Investments, LP

    Shares: 0 · Class: 0%

  • Frederick V. Fortmiller, Jr.

    Shares: 150,000 · Class: 0.31%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-072232
Form type
SCHEDULE 13G/A
Filer
Aspire Biopharma Holdings, Inc.
CIK
CIK 1847345
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub